IP Verse

Dr. Schon, Neymeyr & Partner Patentanwalte Mbb opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Dr. Schon, Neymeyr & Partner Patentanwalte Mbb

Patent Number:
EP3626270
Title:
New Use
Applicant:
NOVARTIS AG
Opposition Date:
Jul 10, 2024
Patent Number:
EP3294283
Title:
Sacubitril-Valsartan Dosage Regimen For Treating Heart Failure
Applicant:
NOVARTIS AG
Opposition Date:
Nov 30, 2023
Patent Number:
EP3067043
Title:
Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor
Applicant:
NOVARTIS AG
Opposition Date:
Aug 24, 2023
Patent Number:
EP3448416
Title:
Semaglutide In Cardiovascular Conditions
Applicant:
NOVO NORDISK A/S
Opposition Date:
May 10, 2023
Patent Number:
EP2653873
Title:
Compositions And Uses For Treating Multiple Sclerosis
Applicant:
BIOGEN IDEC MA INC.
Opposition Date:
Apr 20, 2023
Patent Number:
EP2959894
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
NOVARTIS AG
Opposition Date:
Jan 23, 2023
Patent Number:
EP3582468
Title:
Method For Determining A Degree Of Deception For A Single Phishing Attack Against A Subject
Applicant:
IT-SEAL GMBH
Opposition Date:
Nov 14, 2022
Patent Number:
EP3560500
Title:
Progesterone Formulations
Applicant:
THERAPEUTICSMD, INC.
Opposition Date:
Sep 22, 2022
Patent Number:
EP3429928
Title:
Method For Manufacturing A Cellulose Product, Cellulose Product Forming Apparatus And Cellulose Product
Applicant:
PULPAC AB
Opposition Date:
Aug 10, 2022
Patent Number:
EP2459555
Title:
Processes For Crystallization Of Rivaroxaban
Applicant:
KRKA, D.D., NOVO MESTO
Opposition Date:
Aug 2, 2022

Competitors of Dr. Schon, Neymeyr & Partner Patentanwalte Mbb

NOVARTIS AG

IT-SEAL GMBH

NOVO NORDISK A/S

Want to track Dr. Schon, Neymeyr & Partner Patentanwalte Mbb?

Feel free to send us a message here and we will get back to you